StockWatch
·

ICRA LTD. Q1 FY27 Results

ICRAQ1 FY27 Results
Filing
Result:Good· Market: UpOne-off gainMargin expansionRecord quarter
MetricValueQ4 FY26Q1 FY26
Revenue163.37 Cr6.6%31.2%
Total Income190.99 Cr1.0%28.3%
Expenditure119.26 Cr2.6%31.8%
PBT76.12 Cr4.6%30.4%
Net Profit56.46 Cr7.2%32.0%
OPM36.41%3.37pp4.48pp
NPM29.56%1.69pp0.83pp
EPS58.367.1%32.3%
View full financials

Adjusted PAT growth is ~13% (core Ratings segment revenue +12.9%) once the ₹4.39Cr PPE-sale and ₹6.76Cr D2K remeasurement one-offs are stripped and inorganic Fintellix consolidation is discounted, with margins expanding — healthy and above-average but not a standout given the reported 32% headline is inflated by one-offs/inorganic mix and Ratings-segment profitability actually softened.

Q1 FY-2027 RESULTS · ICRA

ICRA Q1: consolidated PAT +32% to ₹56 Cr, but ~+13% ex one-offs; Fintellix drives topline

PAT +32.04% YoY · revenue +31.24% · margins expanding

30 Jul 2026 · 3 min read
Revenue

₹163.37 Cr

+31.24% YoY

PAT (consolidated)

₹56.46 Cr

+32.04% YoY

Net margin

29.56%

+0.8pp YoY

EPS

₹58.36

ICRA reported consolidated Q1 FY27 (quarter ended June 30, 2026) revenue from operations of ₹163.37 Cr, up 31.2% YoY (₹124.49 Cr) though down 6.6% sequentially from a seasonally strong Q4, and net profit (incl. minority interest) of ₹56.46 Cr, up 32.0% YoY and 7.2% QoQ. Net margin on total income firmed to 29.6%, from 28.7% a year ago and 27.9% last quarter. The headline growth flatters the underlying picture: the print carries two one-offs — a ₹4.39 Cr exceptional gain on sale of property, plant & equipment, and a ₹6.76 Cr remeasurement gain booked in other income on finalising the D2K acquisition consideration. Stripping both (roughly ₹8.3 Cr post-tax at the 25.8% effective rate) leaves adjusted PAT near ₹48 Cr, an underlying YoY gain of about +13% — steady rather than the +32% reported.

The scoreboard

Q1 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹163.37 Cr-6.6%+31.2%
Expenses₹119.26 Cr+2.6%+31.8%
PAT₹56.46 Cr+7.15%+32.04%
Net margin29.56%+1.7pp+0.8pp
EPS₹58.36+7.1%+32.3%

The revenue jump is also substantially inorganic. Management flagged (Note 7) that the year-ago base excludes Fintellix, consolidated only from October 2025, so the two quarters are not directly comparable. That shows in the mix: the Risk & Analytics segment (formerly Research & Analytics) grew revenue 58.7% YoY to ₹80.56 Cr, while the core Ratings & ancillary services segment rose a healthier 12.9% YoY to ₹83.79 Cr on bank-credit-led demand — the two are now near-equal contributors. Segment profitability diverged: Ratings segment result (before exceptional) actually softened, and the analytics build-out weighs on blended segment margins, consistent with the last concall's caution that a shift toward analytics could compress segment-level margins even as scale improves.

4,618.064,862.035,1065,349.975,593.944,83404-2705-1906-1107-0607-2807-30Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹4,834, down 8.3% over the past month of trading.

₹ Cr
021.0842.1663.2355.99Q4 FY25rev ₹136 Cr42.76Q1 FY26rev ₹124 Cr48.02Q2 FY26rev ₹137 Cr39.06Q3 FY26rev ₹164 Cr52.69Q4 FY26rev ₹175 Cr56.46Q1 FY27rev ₹163 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters.

What management guided (4 FY-2026 call)
Management provided a positive outlook for FY27, anticipating continued steady growth in the Ratings business driven by bank credit, while the Research and Analytics segment is expected to be a significant growth driver, bolstered by the Fintellix acquisition and increasing traction in risk, data, and compliance soluti

This quarter: met

This quarter squarely confirms the FY27 roadmap management set out on the Q4 call — steady Ratings growth plus Risk & Analytics as the swing driver, bolstered by Fintellix — with the acquisition machinery still running: ICRA Analytics moved to 100% of D2K for ₹32.02 Cr this quarter, and post-quarter the company mopped up the residual 1.25% of Fintellix for ₹3.17 Cr, making both wholly owned. There is no formal numeric revenue or margin guidance on record, so the print is best read against management's qualitative "steady Ratings, analytics-led growth, margin gains via operating leverage" framing — which it met. No brokerage consensus preview is published for ICRA, so a beat/miss versus street cannot be established. Standalone (the rated parent) tells a quieter story: revenue ₹81.79 Cr (+13.3% YoY) and PAT ₹35.09 Cr (+16.4% YoY), the divergence reflecting how much of the group's growth now sits in the analytics subsidiaries rather than the parent.

  • W1

    Whether Risk & Analytics can sustain its scale-up without further one-off gains — underlying (ex-one-off) PAT growth was ~13% vs 32% reported

  • W2

    Ratings segment margin trajectory: segment result before exceptional dipped even as revenue grew 12.9% YoY — watch for operating-leverage recovery

  • W3

    First fully-consolidated Fintellix quarter (from Q3 FY27) that removes the Note-7 comparability caveat and shows clean organic analytics growth

Clean digital filing. Consolidated PBT (₹76.12 Cr) exceeds pre-exceptional profit (₹71.73 Cr) due to a ₹4.39 Cr exceptional gain on sale of PPE; other income also carries a ₹6.76 Cr one-off D2K remeasurement gain (Note 5). Consolidated PAT of ₹56.46 Cr is total incl. NCI (owners' share ₹56.16 Cr); EPS 58.36 is on owners' profit. Note 7: year-ago quarter excludes Fintellix (acquired Oct 2025), so YoY not strictly like-for-like.

Informational and educational content only. Not investment advice.

ICRA LTD. (ICRA) Q1 FY27 Results — StockWatch